Biography and Research Information
OverviewAI-generated summary
Tsung‐Jen Liao's research focuses on understanding the mechanisms and genetic factors underlying drug-induced liver injury (DILI). His work utilizes computational approaches, including quantitative structure-activity relationship (QSAR) modeling and machine learning, to predict hepatotoxicity and identify risk factors for DILI. Liao has investigated the role of genetic variations, such as single-nucleotide polymorphisms (SNPs) in HLA class II genes and GBP4, in influencing transplant-free survival and susceptibility to acute liver failure. His studies also examine drug interactions with UDP-Glucuronosyltransferase (UGT) enzymes as predictors of DILI. Additionally, Liao has analyzed medical device reports to understand adverse events and sex-based differential effects. His scholarship metrics include an h-index of 4 with 30 citations across 9 publications.
Metrics
- h-index: 8
- Publications: 23
- Citations: 300
Selected Publications
-
Identification of Genetic Risk Factors Associated With Herbal and Dietary Supplement–Induced Acute Liver Failure Using Whole Exome Sequencing Analysis (2025)
-
Genetic Variants of <i>GBP4</i>: Reduced Risks for Drug‐Induced Acute Liver Failure in Non‐Finnish European Population (2025)
-
Drug interaction with UDP-Glucuronosyltransferase (UGT) enzymes is a predictor of drug-induced liver injury (2024)
-
Medical device report analyses from MAUDE: Device and patient outcomes, adverse events, and sex-based differential effects (2024)
-
QSAR modeling for predicting drug-induced liver injury (2023)
-
DILIrank dataset for QSAR modeling of drug-induced liver injury (2023)
-
Computational Modeling for the Prediction of Hepatotoxicity Caused by Drugs and Chemicals (2023)
-
Whole Exome Sequencing Reveals Genetic Variants in HLA Class II Genes Associated With Transplant-free Survival of Indeterminate Acute Liver Failure (2022)
-
Machine Learning to Identify Interaction of Single-Nucleotide Polymorphisms as a Risk Factor for Chronic Drug-Induced Liver Injury (2021)
Collaboration Network
Top Collaborators
- Drug interaction with UDP-Glucuronosyltransferase (UGT) enzymes is a predictor of drug-induced liver injury
- Machine Learning to Identify Interaction of Single-Nucleotide Polymorphisms as a Risk Factor for Chronic Drug-Induced Liver Injury
- Medical device report analyses from MAUDE: Device and patient outcomes, adverse events, and sex-based differential effects
- Whole Exome Sequencing Reveals Genetic Variants in HLA Class II Genes Associated With Transplant-free Survival of Indeterminate Acute Liver Failure
- Computational Modeling for the Prediction of Hepatotoxicity Caused by Drugs and Chemicals
Showing 5 of 9 shared publications
- Whole Exome Sequencing Reveals Genetic Variants in HLA Class II Genes Associated With Transplant-free Survival of Indeterminate Acute Liver Failure
- Computational Modeling for the Prediction of Hepatotoxicity Caused by Drugs and Chemicals
- DILIrank dataset for QSAR modeling of drug-induced liver injury
- Whole Exome Sequencing Reveals Genetic Variants in HLA Class II Genes Associated With Transplant-free Survival of Indeterminate Acute Liver Failure
- Genetic Variants of <i>GBP4</i>: Reduced Risks for Drug‐Induced Acute Liver Failure in Non‐Finnish European Population
- Identification of Genetic Risk Factors Associated With Herbal and Dietary Supplement–Induced Acute Liver Failure Using Whole Exome Sequencing Analysis
- Whole Exome Sequencing Reveals Genetic Variants in HLA Class II Genes Associated With Transplant-free Survival of Indeterminate Acute Liver Failure
- Genetic Variants of <i>GBP4</i>: Reduced Risks for Drug‐Induced Acute Liver Failure in Non‐Finnish European Population
- Identification of Genetic Risk Factors Associated With Herbal and Dietary Supplement–Induced Acute Liver Failure Using Whole Exome Sequencing Analysis
- Machine Learning to Identify Interaction of Single-Nucleotide Polymorphisms as a Risk Factor for Chronic Drug-Induced Liver Injury
- Computational Modeling for the Prediction of Hepatotoxicity Caused by Drugs and Chemicals
- Whole Exome Sequencing Reveals Genetic Variants in HLA Class II Genes Associated With Transplant-free Survival of Indeterminate Acute Liver Failure
- Genetic Variants of <i>GBP4</i>: Reduced Risks for Drug‐Induced Acute Liver Failure in Non‐Finnish European Population
- Whole Exome Sequencing Reveals Genetic Variants in HLA Class II Genes Associated With Transplant-free Survival of Indeterminate Acute Liver Failure
- Genetic Variants of <i>GBP4</i>: Reduced Risks for Drug‐Induced Acute Liver Failure in Non‐Finnish European Population
- Computational Modeling for the Prediction of Hepatotoxicity Caused by Drugs and Chemicals
- DILIrank dataset for QSAR modeling of drug-induced liver injury
- DILIrank dataset for QSAR modeling of drug-induced liver injury
- Identification of Genetic Risk Factors Associated With Herbal and Dietary Supplement–Induced Acute Liver Failure Using Whole Exome Sequencing Analysis
- Genetic Variants of <i>GBP4</i>: Reduced Risks for Drug‐Induced Acute Liver Failure in Non‐Finnish European Population
- Identification of Genetic Risk Factors Associated With Herbal and Dietary Supplement–Induced Acute Liver Failure Using Whole Exome Sequencing Analysis
- Machine Learning to Identify Interaction of Single-Nucleotide Polymorphisms as a Risk Factor for Chronic Drug-Induced Liver Injury
- Whole Exome Sequencing Reveals Genetic Variants in HLA Class II Genes Associated With Transplant-free Survival of Indeterminate Acute Liver Failure
- Whole Exome Sequencing Reveals Genetic Variants in HLA Class II Genes Associated With Transplant-free Survival of Indeterminate Acute Liver Failure
- Computational Modeling for the Prediction of Hepatotoxicity Caused by Drugs and Chemicals
- Computational Modeling for the Prediction of Hepatotoxicity Caused by Drugs and Chemicals
Similar Researchers
Based on overlapping research topics